Infectious Diseases (except HIV/AIDS)

  1. Clinical Outcomes in Hospitalized Vaccine-Breakthrough Coronavirus Disease 2019 Cases Compared With Contemporary Unvaccinated Hospitalized Adults

    1. Marcelo Wolff
    2. Margarita Gilabert
    3. Rodrigo Hernández

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021

    1. Anthony O. Etyang
    2. Ifedayo Adetifa
    3. Richard Omore
    4. Thomas Misore
    5. Abdhalah K. Ziraba
    6. Maurine A. Ng’oda
    7. Evelyn Gitau
    8. John Gitonga
    9. Daisy Mugo
    10. Bernadette Kutima
    11. Henry Karanja
    12. Monica Toroitich
    13. James Nyagwange
    14. James Tuju
    15. Perpetual Wanjiku
    16. Rashid Aman
    17. Patrick Amoth
    18. Mercy Mwangangi
    19. Kadondi Kasera
    20. Wangari Ng’ang’a
    21. Donald Akech
    22. Antipa Sigilai
    23. Boniface Karia
    24. Angela Karani
    25. Shirine Voller
    26. Charles N. Agoti
    27. Lynette I. Ochola-Oyier
    28. Mark Otiende
    29. Christian Bottomley
    30. Amek Nyaguara
    31. Sophie Uyoga
    32. Katherine Gallagher
    33. Eunice W. Kagucia
    34. Dickens Onyango
    35. Benjamin Tsofa
    36. Joseph Mwangangi
    37. Eric Maitha
    38. Edwine Barasa
    39. Philip Bejon
    40. George M. Warimwe
    41. J. Anthony G. Scott
    42. Ambrose Agweyu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Heterologous ChAdOx1-BNT162b2 vaccination in Korean cohort induces robust immune and antibody responses that includes Omicron

    1. Hye Kyung Lee
    2. Jinyoung Go
    3. Heungsup Sung
    4. Seong Who Kim
    5. Mary Walter
    6. Ludwig Knabl
    7. Priscilla A. Furth
    8. Lothar Hennighausen
    9. Jin Won Huh

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial

    1. Katia Abarca
    2. Carolina Iturriaga
    3. Marcela Urzúa
    4. Nicole Le Corre
    5. Augusto Pineda
    6. Carolina Fernández
    7. Angélica Domínguez
    8. Pablo A. González
    9. Susan M. Bueno
    10. Paulina Donato
    11. Pilar Espinoza
    12. Daniela Fuentes
    13. Marcela González
    14. Paula Guzmán
    15. Paula Muñoz-Venturelli
    16. Carlos M. Pérez
    17. Marcela Potin
    18. Álvaro Rojas
    19. José V. González-Aramundiz
    20. Nicolás M. S. Gálvez
    21. Francisca Aguirre-Boza
    22. Sofía Aljaro
    23. Luis Federico Bátiz
    24. Yessica Campisto
    25. Mariela Cepeda
    26. Aarón Cortés
    27. Sofía López
    28. María Loreto Pérez
    29. Andrea Schilling
    30. Alexis M. Kalergis
    31. on behalf of the CoronaVac03CL Study Group

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Time to reinfection and vaccine breakthrough SARS-CoV-2 infections: a retrospective cohort study

    1. Sevda Molani
    2. Andrew M. Baumgartner
    3. Yeon Mi Hwang
    4. Venkata R. Duvvuri
    5. Jason D. Goldman
    6. Jennifer J. Hadlock

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Effectiveness of Covid-19 Vaccines against the SARS-COV-2-Delta (B.1.617.2) in China-A Real World Study

    1. Xinge Ma
    2. Jianfeng Han
    3. Hongxia Li
    4. Chang Liu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Validating saliva as a biological sample for cost-effective, rapid and routine screening for SARS-CoV-2

    1. B.R. Ansil
    2. Carolin Elizabeth George
    3. Sindhulina Chandrasingh
    4. Ashwin Viswanathan
    5. Mukund Thattai
    6. Padinjat Raghu
    7. Santhosha Devadiga
    8. Arun Geetha Harikumar
    9. Pulleri Kandi Harsha
    10. Indu Nair
    11. Uma Ramakrishnan
    12. Satyajit Mayor

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Acoustic Epidemiology of Pulmonary Tuberculosis (TB) & Covid19 Leveraging explainable AI/ML

    1. Rahul Pathri
    2. Shekhar Jha
    3. Samarth Tandon
    4. Suryakanth Gangi Shetty

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Cumulative seroprevalence among healthcare workers after the first wave of the COVID-19 pandemic in El Salvador, Central America

    1. Yu Nakagama
    2. Maria-Virginia Rodriguez-Funes
    3. Rhina Dominguez
    4. Katherine-Sofia Candray-Medina
    5. Naoto Uemura
    6. Evariste Tshibangu-Kabamba
    7. Yuko Nitahara
    8. Natsuko Kaku
    9. Akira Kaneko
    10. Yasutoshi Kido

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Clinical manifestations and disease severity of SARS-CoV-2 infection among infants in Canada

    1. Pierre-Philippe Piché-Renaud
    2. Luc Panetta
    3. Daniel S. Farrar
    4. Charlotte Moore-Hepburn
    5. Olivier Drouin
    6. Jesse Papenburg
    7. Marina I. Salvadori
    8. Melanie Laffin
    9. Fatima Kakkar
    10. Shaun K. Morris
    11. on behalf of the Canadian Paediatric Surveillance Program COVID-19 Study Team

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 205 of 716 Next